- Home
- MD vs ARDX Comparison
MD vs ARDX Comparison
Compare MD & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MD
- ARDX
- Stock Information
- Founded
- MD 1979
- ARDX 2007
- Country
- MD United States
- ARDX United States
- Employees
- MD N/A
- ARDX N/A
- Industry
- MD Hospital/Nursing Management
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- MD Health Care
- ARDX Health Care
- Exchange
- MD Nasdaq
- ARDX Nasdaq
- Market Cap
- MD 1.0B
- ARDX 1.2B
- IPO Year
- MD 1995
- ARDX 2014
- Fundamental
- Price
- MD $13.84
- ARDX $5.01
- Analyst Decision
- MD Buy
- ARDX Buy
- Analyst Count
- MD 7
- ARDX 7
- Target Price
- MD $15.21
- ARDX $10.58
- AVG Volume (30 Days)
- MD 722.4K
- ARDX 5.3M
- Earning Date
- MD 02-20-2025
- ARDX 02-20-2025
- Dividend Yield
- MD N/A
- ARDX N/A
- EPS Growth
- MD N/A
- ARDX N/A
- EPS
- MD N/A
- ARDX N/A
- Revenue
- MD $2,006,998,000.00
- ARDX $251,849,000.00
- Revenue This Year
- MD $3.13
- ARDX $168.07
- Revenue Next Year
- MD N/A
- ARDX $16.66
- P/E Ratio
- MD N/A
- ARDX N/A
- Revenue Growth
- MD N/A
- ARDX 87.57
- 52 Week Low
- MD $6.62
- ARDX $4.32
- 52 Week High
- MD $16.41
- ARDX $10.13
- Technical
- Relative Strength Index (RSI)
- MD 53.44
- ARDX 46.43
- Support Level
- MD $13.57
- ARDX $4.98
- Resistance Level
- MD $14.10
- ARDX $6.07
- Average True Range (ATR)
- MD 0.41
- ARDX 0.40
- MACD
- MD 0.12
- ARDX 0.02
- Stochastic Oscillator
- MD 85.06
- ARDX 27.15
About MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.